Anslyn Freije, Melissa Abt, Tinslee Dilday, Elizabeth Yeh

Validation of Rubicon's Autophagy Inhibition Function Through HUNK Phosphorylation

Introduction

Validation of rubicon's autophagy inhibition function through hunk phosphorylation. Discover how HUNK phosphorylation affects Rubicon's autophagy inhibition, a key mechanism in HER2+ breast cancer cell growth. Essential for novel treatment insights.

Abstract

Background and Hypothesis: HER2+ breast cancer uses the human epidermal growth receptor 2 (HER2) protein to grow. As an aggressive form of breast cancer, it accounts for ~20% of all breast cancer diagnoses worldwide. Previous studies show Hormonally Up-regulated Neu-associated Kinase (HUNK) is up-regulated in HER2+ breast cancer. HUNK plays an important role in the cellular process of autophagy, which recycles cellular components into new usable components. Increased autophagy, through HUNK activity, allows for improved survival and proliferation of cancer cells. Autophagy is mediated through a complex of proteins, including Beclin-1, HUNK, Rubicon, UVRAG, and Vps34. In this complex, Rubicon is responsible for the inhibition of autophagy. However, phosphorylation of Rubicon by HUNK inhibits this function, thus promoting autophagy. This phosphorylation of Rubicon is hypothesized to cause its dissociation from the autophagy proteins. To further understand this, we looked at the interaction of Rubicon with UVRAG and SQSTMI in the presence and absence of HUNK, to validate this complex as a means for regulation of the Rubicon interactome. Experimental Design: 293T cells were cultured and transfected with pcDNA, wt-Rubicon, wt-Rubicon+wt-HUNK, or wt-Rubicon+ kinase-deficient HUNK-K91M plasmids. These cells were lysed to perform whole cell extraction and immunoprecipitation. The proteins of interest were visualized via Western blots. Results: Autophagy proteins, UVRAG and SQSTM1, were unable to be visualized after multiple attempts to optimize the protocol. However, it was shown that when HUNK kinase activity was eliminated in HUNK-K91M there was a decrease in HUNK interaction with Rubicon. Conclusion and Potential Impact: Further studies should be done to assess whether HUNK kinase activity is required to stabilize binding to Rubicon. Additionally, alternative techniques, like microscopy or HER2+ cancer cells, should be used to visualize the interaction between Rubicon and autophagy proteins. Understanding the Rubicon interactome and the role of HUNK phosphorylation is imperative for better understanding of HER2+ cancer and effective treatments.

Review

This abstract presents a compelling hypothesis regarding the role of HUNK phosphorylation in regulating Rubicon's autophagy inhibition function, particularly in the context of HER2+ breast cancer. The background effectively establishes the clinical relevance of HER2+ cancer, the upregulation of HUNK, and its proposed mechanism of promoting autophagy by inactivating Rubicon. The idea that HUNK-mediated phosphorylation leads to Rubicon's dissociation from key autophagy proteins (UVRAG, SQSTM1) is an interesting and plausible regulatory mechanism that, if validated, could offer significant insights into cancer cell survival and potential therapeutic targets. The authors clearly articulate the specific proteins they aimed to examine within the Rubicon interactome. However, the experimental execution and results presented are significantly limited. The core aim of the study, to visualize the interaction between Rubicon and the autophagy proteins UVRAG and SQSTM1 in the presence and absence of HUNK, was unfortunately not achieved due to persistent technical difficulties in visualizing these proteins via Western blot. This failure undermines the primary objective of the work and leaves the central hypothesis untested. While the observation that kinase-deficient HUNK-K91M showed decreased interaction with Rubicon is noted, it only addresses the stability of the HUNK-Rubicon binding, not the proposed effect of HUNK phosphorylation on Rubicon's interaction with other autophagy regulators or its overall function. Furthermore, the use of 293T cells, rather than HER2+ breast cancer cell lines, is a notable limitation given the strong clinical context established in the background. In conclusion, while the scientific premise of this work is strong and addresses a significant area of cancer biology, the abstract as presented lacks the conclusive experimental evidence necessary to validate its central hypothesis. The inability to visualize key proteins, UVRAG and SQSTM1, represents a critical methodological hurdle that prevented any meaningful conclusions about the Rubicon interactome. Future studies are essential to overcome these technical limitations, ideally by optimizing Western blot protocols, exploring alternative visualization techniques such as microscopy or proximity ligation assays, and employing more biologically relevant HER2+ cancer cell models. Only then can the proposed mechanism of HUNK-mediated Rubicon phosphorylation and its impact on autophagy be definitively investigated to potentially inform novel therapeutic strategies.

Full Text

Comments

You need to be logged in to post a comment.